Effect of pentylenetetrazol treatment on cholecystokinin mRNA and peptide levels in rat hippocampus and cortex

Brain Research

Volumn 779, Issue 1-2, 1998, Pages 320-323

  Takeda, K ^a   Nakata, K ^a   Takahashi, S ^a   Chikuma, T ^a   Kato, T ^a  

^a Research and Development Department   (Japan)

Author keywords

Cholecystokinin (CCK); Clonic; Epilepsy; Frontal cortex; Hippocampus; MRNA; Pentylenetetrazol (PTZ); Rat brain

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ LIKE PEPTIDE; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE; TEMPORAL CORTEX;

EID: 0031963895     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01179-7     Document Type: Article

References (17)

1. M.C. Beinfeld An HPLC and RIA analysis of the cholecystokinin peptides in rat brain Neuropeptides 1 1981 203 209
2. B. Gruber S. Greber G. Sperk Kainic acid seizures cause enhanced expression of cholecystokinin-octapeptide in the cortex and hippocampus of the rat Synapse 15 1993 221 228
3. Y. Hayashi Y. Hattori A. Moriwaki Y.F. Lu Y. Hori Increases in brain polyamine concentrations in chemical kindling and single convulsion induced by pentylenetetrazol in rats Neurosci. Lett. 149 1993 63 66
4. B antagonist LY288513 Pharmacol. Biochem. Behav. 53 1996 493 502
5. C. Humpel C. Wetmore L. Olson Regulation of brain-derived neurotrophic factor messenger RNA and protein at the cellular level in pentylenetetrazol-induced epileptic seizures Neuroscience 53 1993 909 918
6. T. Kàdàr A. Pest B. Penke G. Telegdy Inhibition of seizures induced by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration Neuropharmacology 23 1984 955 961
7. G.M. Kasof A. Mandelzys S.D. Maika R.E. Hammer T. Curran J.I. Morgan Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c- fos - lac Z transgenic rats J. Neurosci. 15 1995 4238 4249
8. T. Kato Y. Emi M. Takita Y. Kushima Time dependent changes in the concentrations of immunoreactive cholecystokinin octapeptide sulfate in rat brain regions after systemic injection of picrotoxin Neurochem. Int. 12 1988 493 497
9. J. Marksteiner H. Lassman A. Saria C. Humpel D.K. Meyer G. Sperk Neuropeptide levels after pentylenetetrazol kindling in the rat Eur. J. Neurosci. 2 1990 98 103
10. K. Nakata N. Matsushima S. Takahashi T. Kato Measurement of cholecystokinin mRNA and peptide in rat brain regions after chronic administration of pentetrazol Jpn. J. Pharmacol. 71 1996 186 Suppl.
11. K. Osonoe N. Mori K. Suzuki M. Osonoe Antiepleptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rat Brain Res. 663 1994 338 340
12. A.M. Planas M.A. Soriano I. Ferrer E.R. Farrè Regional expression of inducible heat shock protein-70 mRNA in the rat brain following administration of convulsant drugs Mol. Brain Res. 27 1994 127 137
13. P. Romualdi G. Lesa A. Donatini G. Baiboni R. Tomatis S. Ferri Alterations in vasoactive intestinal polypeptide-related peptides after pentylenetetrazol-induced seizures in rat brain Eur. J. Pharmacol. 229 1992 149 153
14. G. Sperk Kainic acid seizures in the rat Prog. Neurobiol. 42 1994 1 32
15. K. Takeda F. Uchiumi M. Takita T. Kato A rapid enzyme immunoassay for cholecystokinin octapeptide sulfate Neurochem. Int. 15 1989 55 60
16. H. Yamamoto T. Kato Enzyme immunoassay for cholecystokinin octapeptide sulfate and its application J. Neurochem. 46 1986 702 707
17. G. Zetler Anticonvulsant effects of caerulein and cholecystokinin octapeptide, compared with those of diazepam Eur. J. Pharmacol. 65 1980 297 300